Please login to the form below

Not currently logged in
Email:
Password:

Still's disease

This page shows the latest Still's disease news and features for those working in and with pharma, biotech and healthcare.

FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision

FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision

the patient-centred outcome of clinical benefit, which has been required of all previous emerging treatments for Alzheimer’s disease,” the institute added. ... Still, patient representatives have counted the approval as a significant win for millions

Latest news

More from news
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...